PURPOSE: To identify the measures of focal and diffuse white matter (WM) abnormalities that are related to whole-brain, deep, and cortical gray matter (GM) atrophy in long-standing multiple sclerosis (MS). MATERIALS AND METHODS: The institutional review board approved the study; all subjects gave written informed consent. Magnetic resonance (MR) imaging was performed at 3 T in 208 patients with MS of long-standing duration (disease duration ≥ 10 years) and in 60 healthy control subjects. Normalized GM volume (NGMV), normalized WM volume (NWMV), normalized deep GM volume (NDGMV), cortical thickness, and normalized lesion volume (NLV) were quantified. Tissue integrity of normal-appearing WM (NAWM) and lesions was measured by using diffusion-tensor MR imaging. Multivariate associations between measures of GM atrophy and WM abnormalities were assessed in the patient group by using multiple linear regression. RESULTS: NGMV, NDGMV, and cortical thickness were reduced in patients with MS (all P < .001). The final model for NGMV consisted of NWMV, NLV, and patient age and sex (adjusted R(2) = 0.58, P < .001). NWMV, NLV, and patient sex were the explanatory variables for NDGMV (adjusted R(2) = 0.75, P < .001). The model for cortical thickness consisted of fractional anisotropy of NAWM, NLV, and patient age and sex (adjusted R(2) = 0.32, P < .001). The relationship between GM atrophy and WM abnormalities was weaker in primary and secondary progressive disease than in relapsing-remitting disease. CONCLUSION: Whole-brain and deep GM atrophy were particularly explained by WM atrophy and lesion volume, while cortical atrophy was associated with NAWM integrity loss. The weaker relationship between GM atrophy and WM abnormalities in patients with progressive disease might indicate a more independent neurodegenerative disease process in these patients.
PURPOSE: To identify the measures of focal and diffuse white matter (WM) abnormalities that are related to whole-brain, deep, and cortical gray matter (GM) atrophy in long-standing multiple sclerosis (MS). MATERIALS AND METHODS: The institutional review board approved the study; all subjects gave written informed consent. Magnetic resonance (MR) imaging was performed at 3 T in 208 patients with MS of long-standing duration (disease duration ≥ 10 years) and in 60 healthy control subjects. Normalized GM volume (NGMV), normalized WM volume (NWMV), normalized deep GM volume (NDGMV), cortical thickness, and normalized lesion volume (NLV) were quantified. Tissue integrity of normal-appearing WM (NAWM) and lesions was measured by using diffusion-tensor MR imaging. Multivariate associations between measures of GM atrophy and WM abnormalities were assessed in the patient group by using multiple linear regression. RESULTS: NGMV, NDGMV, and cortical thickness were reduced in patients with MS (all P < .001). The final model for NGMV consisted of NWMV, NLV, and patient age and sex (adjusted R(2) = 0.58, P < .001). NWMV, NLV, and patient sex were the explanatory variables for NDGMV (adjusted R(2) = 0.75, P < .001). The model for cortical thickness consisted of fractional anisotropy of NAWM, NLV, and patient age and sex (adjusted R(2) = 0.32, P < .001). The relationship between GM atrophy and WM abnormalities was weaker in primary and secondary progressive disease than in relapsing-remitting disease. CONCLUSION: Whole-brain and deep GM atrophy were particularly explained by WM atrophy and lesion volume, while cortical atrophy was associated with NAWM integrity loss. The weaker relationship between GM atrophy and WM abnormalities in patients with progressive disease might indicate a more independent neurodegenerative disease process in these patients.
Authors: Benedetta Bodini; Declan Chard; Daniel R Altmann; Daniel Tozer; David H Miller; Alan J Thompson; Claudia Wheeler-Kingshott; Olga Ciccarelli Journal: Neurology Date: 2015-12-16 Impact factor: 9.910
Authors: Martijn D Steenwijk; Marita Daams; Petra J W Pouwels; Lisanne J Balk; Prejaas K Tewarie; Jeroen J G Geurts; Frederik Barkhof; Hugo Vrenken Journal: Hum Brain Mapp Date: 2015-01-27 Impact factor: 5.038
Authors: Constantina A Treaba; Elena Herranz; Valeria T Barletta; Ambica Mehndiratta; Russell Ouellette; Jacob A Sloane; Eric C Klawiter; Revere P Kinkel; Caterina Mainero Journal: J Neurol Date: 2021-02-01 Impact factor: 4.849
Authors: Prejaas Tewarie; Menno M Schoonheim; Daphne I Schouten; Chris H Polman; Lisanne J Balk; Bernard M J Uitdehaag; Jeroen J G Geurts; Arjan Hillebrand; Frederik Barkhof; Cornelis J Stam Journal: Hum Brain Mapp Date: 2014-10-08 Impact factor: 5.038
Authors: Céline Louapre; Sindhuja T Govindarajan; Costanza Giannì; Julien Cohen-Adad; Michael D Gregory; A Scott Nielsen; Nancy Madigan; Jacob A Sloane; Revere P Kinkel; Caterina Mainero Journal: Radiology Date: 2015-09-02 Impact factor: 11.105
Authors: Prejaas Tewarie; Martijn D Steenwijk; Betty M Tijms; Marita Daams; Lisanne J Balk; Cornelis J Stam; Bernard M J Uitdehaag; Chris H Polman; Jeroen J G Geurts; Frederik Barkhof; Petra J W Pouwels; Hugo Vrenken; Arjan Hillebrand Journal: Hum Brain Mapp Date: 2014-07-22 Impact factor: 5.038